RapidAI Announces $25 Million in Series B Funding – Funds to Accelerate the Company’s Growth Globally

Founded in 2011, RapidAI makes the most-widely used advanced cerebrovascular imaging products for patient care, research, and clinical trials. This funding will support the continued advancement of the Rapid® platform and world-class clinical products.

LAVA Therapeutics Announces $83 million Series C Financing

As part of the transaction, Nanna Lüneborg, partner at Novo Ventures, Laia Crespo, EU head of investments at Sanofi Ventures, and Joël Jean-Mairet, managing partner and co-founder of Ysios, joined LAVA as members of the board of directors.

Aidoc Announces Series B Extension to $47M As Market Demand for Proven Radiology AI Soars

The announcement comes as radiology practices continue to choose Aidoc as their core AI solution, tripling the company's revenue since the beginning of 2020, even amidst a global pandemic.

Signifier Medical Technologies Closes $10M Series C Funding Round

Signifier Medical Technologies notes the proceeds from this latest successful fundraising will allow Signifier to invest further in its innovative and non-invasive solutions for patients with sleep disordered breathing conditions.

CoreMap Completes $10.5 Million Series A Financing

CoreMap notes the funds will be used to accelerate the Company’s ongoing product development and their planned regulatory submission of the Company’s first products.

Spine Align Raises $1.75M Series Seed Round

Spine Align reports the financing is led by the Rockies Venture Club, with additional support by members of the Berkeley Angel Network, NO/LA Angel Network, Pasadena Angels, Bellingham Angels, the Abell Foundation, and VentureWell.

Adona Medical, A Shifamed Portfolio Company, Closes $22M In Series A Financing

Adona Medical notes the financing was led by Cormorant Asset Management, with participation from Excelestar Ventures, AMED Ventures, and select angel investors, and included previous debt investments that converted to preferred shares.

PhotoniCare Achieves More Than $7 Million in Funding for Commercial Expansion of First-In-Class Ear Imaging Technology

PhotoniCare, in January of this year, announced that the U.S. Food and Drug Administration had granted clearance for its TOMi™ Scope for non-invasive imaging of the middle ear.